PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 16, 2024Journal of Clinical Oncology6 citationsOpen Access

Metastasis-Free Survival Versus Treatment-Free Survival in Biochemically Recurrent Prostate Cancer: The EMBARK Trial

View Full Paper
DEDavid J. EinsteinMRMeredith M. ReganJSJulia S. Stevens

Key Points

Key points are not available for this paper at this time.

Abstract

What is most important to patients with BCR prostate cancer? Metastasis-free versus treatment-free survival.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Einstein et al. (2024) studied this question.

synapsesocial.com/papers/68e69b09b6db643587620f0ehttps://doi.org/10.1200/jco.24.00279
Ask AI
Helpful
Bookmark
Share
View Full Paper